These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 35744811)
1. TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment. Wang X; Zeng H; Zhu X; Xu D; Tian Q; Wang C; Zhao L; Zhao J; Miao M; Wu X Molecules; 2022 Jun; 27(12):. PubMed ID: 35744811 [TBL] [Abstract][Full Text] [Related]
2. Zeng H; Zhu X; Tian Q; Yan Y; Zhang L; Yan M; Li R; Li X; Wang G; Ma J; Su Y; Zhang X; Ma L; Zhang Z; Wu X Drug Deliv; 2020 Dec; 27(1):848-854. PubMed ID: 32508161 [TBL] [Abstract][Full Text] [Related]
3. ATB Lou D; Lou Z; Lin Y; Shangguan H; Lin Y; Luo Q; Zhang H; Lin G; Chen R; Kou L; Bao S Bioorg Med Chem Lett; 2021 Feb; 33():127728. PubMed ID: 33346010 [TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel water-soluble, rapid-release triptolide prodrug with improved drug-like properties and high efficacy in human acute myeloid leukemia. Kang D; Pan X; Song Y; Liu Y; Wang D; Zhu X; Wang J; Hu L Eur J Med Chem; 2022 Dec; 243():114694. PubMed ID: 36115206 [TBL] [Abstract][Full Text] [Related]
5. Triptolide and Its Derivatives as Cancer Therapies. Noel P; Von Hoff DD; Saluja AK; Velagapudi M; Borazanci E; Han H Trends Pharmacol Sci; 2019 May; 40(5):327-341. PubMed ID: 30975442 [TBL] [Abstract][Full Text] [Related]
6. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085 [TBL] [Abstract][Full Text] [Related]
7. Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer. Chen Y; Yang J; Wang C; Wang T; Zeng Y; Li X; Zuo Y; Chen H; Zhang C; Cao Y; Sun C; Wang M; Cao X; Ge X; Liu Y; Zhang G; Deng Y; Peng C; Lu A; Lu J J Exp Clin Cancer Res; 2024 Jul; 43(1):207. PubMed ID: 39054545 [TBL] [Abstract][Full Text] [Related]
8. Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer. Zeng X; Zhu X; Tian Q; Tan X; Sun N; Yan M; Zhao J; Wu X; Li R; Zhang Z; Zeng H Drug Deliv; 2022 Dec; 29(1):89-98. PubMed ID: 34964425 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and in vitro evaluation of triptolide-lysozyme conjugate for renal targeting delivery of triptolide. Zheng Q; Gong T; Sun X; Zhang ZR Arch Pharm Res; 2006 Dec; 29(12):1164-70. PubMed ID: 17225468 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer. Wang Y; Liu T; Li H J Biomater Sci Polym Ed; 2016; 27(7):545-56. PubMed ID: 26786618 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, Characterization, and Evaluation of Triptolide Cell-Penetrating Peptide Derivative for Transdermal Delivery of Triptolide. Tian T; Song Y; Li K; Sun Y; Wang Q Mol Pharm; 2018 Feb; 15(2):560-570. PubMed ID: 29307194 [TBL] [Abstract][Full Text] [Related]
12. Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation. He QL; Minn I; Wang Q; Xu P; Head SA; Datan E; Yu B; Pomper MG; Liu JO Angew Chem Int Ed Engl; 2016 Sep; 55(39):12035-9. PubMed ID: 27574181 [TBL] [Abstract][Full Text] [Related]
13. Detoxification strategies of triptolide based on drug combinations and targeted delivery methods. Cao Z; Liu B; Li L; Lu P; Yan L; Lu C Toxicology; 2022 Mar; 469():153134. PubMed ID: 35202762 [TBL] [Abstract][Full Text] [Related]
14. Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity. Zheng W; Wang C; Ding R; Huang Y; Li Y; Lu Y Int J Pharm; 2019 Dec; 572():118721. PubMed ID: 31626922 [TBL] [Abstract][Full Text] [Related]
15. pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma. Ling D; Xia H; Park W; Hackett MJ; Song C; Na K; Hui KM; Hyeon T ACS Nano; 2014 Aug; 8(8):8027-39. PubMed ID: 25093274 [TBL] [Abstract][Full Text] [Related]
16. Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization. Lai K; Li Y; Gong Y; Li L; Huang C; Xu F; Zhong X; Jin C Biomed Pharmacother; 2020 Nov; 131():110737. PubMed ID: 32932044 [TBL] [Abstract][Full Text] [Related]
17. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats. Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813 [TBL] [Abstract][Full Text] [Related]
18. Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury. Deng X; Zeng T; Li J; Huang C; Yu M; Wang X; Tan L; Zhang M; Li A; Hu J Biomater Sci; 2019 Dec; 7(12):5312-5323. PubMed ID: 31617509 [TBL] [Abstract][Full Text] [Related]
19. Triptolide Modulates TREM-1 Signal Pathway to Inhibit the Inflammatory Response in Rheumatoid Arthritis. Fan D; He X; Bian Y; Guo Q; Zheng K; Zhao Y; Lu C; Liu B; Xu X; Zhang G; Lu A Int J Mol Sci; 2016 Apr; 17(4):498. PubMed ID: 27049384 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of triptolide and its prodrug MC002 in dog blood by LC-MS/MS and its application in pharmacokinetic studies. Zhuang XM; Liu PX; Zhang YJ; Li CK; Li Y; Wang J; Zhou L; Zhang ZQ J Ethnopharmacol; 2013 Oct; 150(1):131-7. PubMed ID: 23994469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]